View Filing Data

474

^[1]

474

Conversion of Series A Preferred Convertible Preferred stock, classified as mezzanine equity

(2,754)

Balance at Dec. 31, 2011

2,865

170

5,449

(2,754)

Balance at Jun. 08, 2011

Conversion of Series A Preferred Convertible Preferred stock, classified as equity

14,677

1,724

Conversion of derivative warrants into equity warrants

3,748

Conversion of Series A Preferred Convertible Preferred stock, classified as mezzanine equity

(46,499)

Balance at Jun. 30, 2013

135,695

830

181,364

(46,499)

Balance at Dec. 31, 2011

2,865

170

5,449

(2,754)

Issuance of shares of common stock

31,148

31,052

Recording of equity instruments upon Merger, net of fair value of issued warrants $21,954 and issuance cost of $463

8,087

8,084

54,961

152

54,809

Issuance of warrants

2,883

Conversion of Series A Preferred Convertible Preferred stock, classified as equity

201

(201)

Exercise of warrants

22,932

22,856

Exercise of stock options and vesting of RSUs

509

501

Shares issued for acquisition of patents

750

748

Issuance of shares in connection with a financing round, net of issuance cost $39

44,962

103

44,859

(20,841)

Balance at Dec. 31, 2012

148,332

819

171,108

(23,595)

Exercise of stock options and vesting of RSUs

6,116

Exercise of warrants

250

249

153

143

Conversion of derivative warrants into equity warrants

3,748

Significant Accounting and Reporting Policies

(22,904)

Balance at Jun. 30, 2013

$ 135,695

$ 830

$ 181,364

$ (46,499)

[1]	Represents amounts less than $1

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2012 USD ($)
Fair Value Of Warrant Issued	$ 21,954
Private Financing [Member]
Issuance of stock, issuance costs	52
Private Financing One [Member]
Issuance of stock, issuance costs	39
Common Stock Shares [Member]
Issuance of stock, issuance costs	$ 463

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended		25 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013
Cash flows from operating activities
Net loss	$ (22,904)	$ (3,712)	$ (46,499)
Adjustments to reconcile net cash flows used in operating activities:
Depreciation and amortization	2,567	313	5,397
Change in deferred tax assets and liabilities	0	0	(58)
Stock-based compensation	6,116	169	14,677
Issuance of warrants	0	0	2,883
Assignment of patents	(100)	0	(100)
Decrease (increase) in fair value of warrants	1,866	0	(4,981)
Exchange rate losses	4	0	12
Changes in current assets and liabilities
Decrease (increase) in receivables, prepaid expenses and other current assets	73	7	(161)
Increase in payables and accruals	1,412	593	1,868
Net cash used in operating activities	(10,966)	(2,630)	(26,962)
Cash flows from investing activities
Acquisition of property and equipment	(31)	(11)	(248)
Deposit in short-term investments	(3,120)	0	(3,120)
Acquisition of patents	0	0	(25,944)
Increase (decrease) in deposits	8	0	(38)
Cash acquired as part of acquisition of Vringo (1)	0	0	3,326
Net cash used in investing activities	(3,143)	(11)	(26,024)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance cost of $52	0	0	31,148
Proceeds from issuance of common stock, net of issuance cost of $39	0	0	44,962
Proceeds from issuance (repayment) of note payable - related party	0	0	0
Proceeds from issuance of preferred stock	0	0	1,800
Proceeds from issuance of common stock	0	0	5,145
Exercise of options and RSUs	153	0	662
Exercise of warrants	174	0	12,449
Net cash provided by financing activities	327	0	96,166
Effect of exchange rate changes on cash and cash equivalents	10	0	8
Increase (decrease) in cash and cash equivalents	(13,772)	(2,641)	43,188
Cash and cash equivalents at beginning of period	56,960	5,212	0
Cash and cash equivalents at end of period	43,188	2,571	43,188
Supplemental disclosure of cash flows information
Interest paid	0	4	17
Income taxes paid	3	0	10
Non-cash investing and financing transactions
Conversion of Series A preferred stock to common stock shares		39	39
Exercise of derivative warrants	76	0	10,733
Non cash acquisition of acquisition of patents through issuance of common stock shares	0	0	750
Conversion of Series A Convertible Preferred stock, classified as mezzanine equity, into common stock, prior to the Merger	0	0	76
Conversion of Series A Convertible Preferred stock, classified as mezzanine equity, into common stock, upon Merger		0	1,724
Conversion of Series A Convertible Preferred stock, classified as equity, into common stock, post-Merger	0	0	201
Conversion of derivative warrants into equity warrants	$ 3,748	$ 0	3,748
(1) Cash acquired as part of acquisition of Vringo
Working capital (excluding cash and cash equivalents)			740
Long term deposit			(8)
Fixed assets, net			(124)
Goodwill			(65,965)
Technology			(10,133)
Fair value of Legal Parent's shares of common stock and vested $0.01 options			58,211
Fair value of warrants and vested stock options			17,443
Long-term liabilities			3,162
Total Cash Acquired During Acqusition			$ 3,326

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2012 USD ($)
Private Financing [Member]
Issuance of stock, issuance costs	$ 52
Private Financing One [Member]
Issuance of stock, issuance costs	$ 39

General	6 Months Ended
General	Jun. 30, 2013
General [Abstract]
General	Note 1. General Vringo, Inc., together with its consolidated subsidiaries (the “Company”), is engaged in the development and monetization of intellectual property worldwide. The Company's intellectual property portfolio consists of over 500 patents and patent applications covering telecom infrastructure, internet search and mobile technologies. The Company’s patents and patent applications have been developed internally and acquired from third parties. The Company operates a global platform for the distribution of mobile social applications and services it develops. On July 19, 2012, Vringo, Inc., a Delaware corporation (“Vringo” or “Legal Parent”), closed a merger transaction (the “Merger”) with Innovate/Protect, Inc., a privately held Delaware corporation (“I/P”), pursuant to an Agreement and Plan of Merger, dated as of March 13, 2012 (the “Merger Agreement”), by and among Vringo, I/P and VIP Merger Sub, Inc., a wholly-owned subsidiary of Vringo (“Merger Sub”). Pursuant to the Merger Agreement, I/P became a wholly-owned subsidiary of Vringo through a merger of I/P with and into Merger Sub, and the former stockholders of I/P received shares of Vringo that constituted a majority of the outstanding shares of Vringo. Immediately following the Merger, approximately 67.61% of the combined company was owned by I/P stockholders on a fully diluted basis, and as a result of this and other factors, I/P was deemed to be the acquiring company for accounting purposes and the transaction was accounted for as a reverse acquisition in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). Accordingly, the Company’s financial statements for periods prior to the Merger reflect the historical results of I/P and not Legal Parent’s historical results prior to the Merger, and the Company’s financial statements for all periods from July 19, 2012 reflect the results of the combined company. Unless specifically noted otherwise, as used throughout these consolidated financial statements, the term “Company” refers to the combined company after the Merger and the business of I/P before the Merger. The terms I/P and Vringo or Legal Parent refer to such entities’ standalone businesses prior to the Merger.

Significant Accounting and Reporting Policies

6 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

Note 2 . Significant Accounting and Reporting Policies

(a) Basis of presentation

The accompanying consolidated financial statements include the accounts of the Legal Parent, I/P and their wholly-owned subsidiaries, and are presented in accordance with instructions to Form 10-Q and, therefore, do not include all disclosures necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with generally accepted accounting principles. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the year ended December 31, 2012 included in the Company's Annual Report on Form 10-K. The results of operations for the three and six month periods ended June 30, 2013 are not necessarily indicative of the results that may be expected for the entire fiscal year or for any other interim period. All significant intercompany balances and transactions have been eliminated in consolidation. These financial statements include the results of operations of I/P and its subsidiaries for all periods presented, with the results of operations of the Legal Parent and its subsidiaries for the period from July 19, 2012 (the effective date of the Merger). Moreover, equity amounts, as well as net loss per common share, presented for comparative periods differ from those previously presented by I/P, due to application of accounting requirements applicable to a reverse acquisition.

(b) Development stage enterprise

The Company’s principal activities to date have been focused on development and enforcement of its intellectual property, and on the research and development of its products. To date, the Company has not generated significant revenues from its principal operations. Accordingly, the Company’s financial statements are presented as those of a development stage enterprise.

(c) Translation into U.S. dollars

The Company conducts significant transactions in foreign currencies, which are recorded at the exchange rate as of the transaction date. All exchange gains and losses from remeasurement of monetary balance sheet items denominated in non-dollar currencies are reflected as non-operating income or expense in the statement of operations, as they arise.

(d) Use of estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results may differ from such estimates. Significant items subject to such estimates and assumptions include valuation of assets assumed and liabilities incurred as part of the Merger, useful lives of the Company’s tangible and intangible assets, valuation of its October 2012 Warrants (as such term is defined below) and derivative warrants, valuation of its s tock-based compensation, deferred tax assets and liabilities, income tax uncertainties and other contingencies.

(e) Cash and cash equivalents

The Company invests its cash in commercial paper, money market deposits and money market funds with financial institutions. The Company has established guidelines relating to diversification and maturities of its investments, in order to minimize credit risk and maintain high liquidity of funds. All highly liquid investments with original maturities of three months or less are considered cash equivalents.

(f) Short-term investments

Short-term investment consist s of investment in commercial paper with an original maturity of twelve months or less. The Company has the ability and intent to hold its current investment in short-term commercial paper until maturity; therefore, it classified such investments as “held-to-maturity ”. Held-to-maturity debt securities are recorded at amortized cost, adjusted for the amortization or accretion of premiums or discounts. Premiums and discounts on debt securities are amortized or accreted over the life of the related held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion is included in non-operating income (expense). Dividend and interest income are recognized when earned.

(g) Revenue recognition

Revenue from patent licensing and enforcement, subscription services and software development is recognized if collection is probable, persuasive evidence of an arrangement exists, the sales price is fixed or determinable and delivery of the service has been rendered. The Company uses management's best estimate of selling price for individual elements in multiple-element arrangements, where other sources of evidence are unavailable.

(h) Cost of revenue

Cost of revenue mainly includes expenses incurred in connection with the Company’s patent enforcement activities, such as legal fees, consulting costs, patent maintenance and other related expenses, as well as the amortization of acquired patents and technology. Legal costs incurred in connection with ongoing litigation are expensed as incurred. Cost of revenue also includes expenses directly related to providing mobile services in launched markets. In addition, these costs include royalty fees for content sales and amortization of prepaid content licenses. Cost of revenue does not include expenses related to product development, integration or support, as these are included in research and development expenses.

( i) Net loss per share data

Basic net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing the net loss for the period by the weighted-average number of shares of common stock plus dilutive potential common stock considered outstanding during the period. Such dilutive shares consist of incremental shares that would be issued upon exercise of the Company’s derivative warrants. The table below presents the computation of basic and diluted net losses per common share for the periods presented:

									Cumulative
									from Inception
	Three months ended June 30,				Six months ended June 30,				to June 30,
	2013		2012		2013		2012		2013
Basic Numerator:
Net loss attributable to shares of common stock	$	(10,940)	$	(1,841)	$	(22,904)	$	(3,712)	$	(46,499)
Basic Denominator:
Weighted average number of shares of common stock outstanding during the period		82,625,295		14,700,170		82,406,883		13,844,037		41,596,664
Weighted average number of penny stock options		114,152		—		145,827		—		113,299
Basic common stock shares outstanding		82,739,447		14,700,170		82,552,710		13,844,037		41,709,963
Basic net loss per common stock share	$	(0.13)	$	(0.13)	$	(0.28)	$	(0.27)	$	(1.11)

Diluted Numerator:
Net loss attributable to shares of common stock	$	(10,940)	$	(1,841)	$	(22,904)	$	(3,712)	$	(46,499)
Increase in net loss attributable to Series 1 warrants		—		—		—		—		(2,482)
Increase in net loss attributable to Preferential Reload warrants		—		—		—		—		(135)
Increase in net loss attributable to Conversion warrants		—		—		—		—		(68)
Increase in net loss attributable to Special Bridge warrants		—		—		—		—		(100)
Diluted net loss attributable to shares of common stock:	$	(10,940)	$	(1,841)	$	(22,904)	$	(3,712)	$	(49,284)

Diluted Denominator:
Weighted average number of shares of common stock outstanding during the period		82,739,447		14,700,170		82,552,710		13,844,037		41,709,963
Weighted average number of Series 1 warrants outstanding during the period		—		—		—		—		1,223,067
Weighted average number of Preferential Reload warrants outstanding during the period		—		—		—		—		75,197
Weighted average number of Conversion warrants outstanding during the period		—		—		—		—		47,497
Weighted average number of Special Bridge warrants outstanding during the period		—		—		—		—		69,477
Diluted common stock shares outstanding		82,739,447		14,700,170		82,552,710		13,844,037		43,125,201
Diluted net loss per common stock share	$	(0.13)	$	(0.13)	$	(0.28)	$	(0.27)	$	(1.14)
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as of June 30, as they had an anti-dilutive impact:
Both vested and unvested options at $0.96-$5.50 exercise price, to purchase an equal number of shares of common stock of the Company		11,805,940		—		11,805,940		—		11,805,940
Unvested $0.01 options to purchase an equal number of shares of common stock of the Company		2,375		—		2,375		—		2,375
Unvested Restricted Stock Units (“RSU”) to issue an equal number of shares of common stock of the Company		2,815,794		—		2,815,794		—		2,815,794
Common stock shares granted, but not yet vested		61,478		2,826,390		61,478		2,826,390		61,478
Warrants to purchase an equal number of shares of common stock of the Company		18,764,114		754,400		18,764,114		754,400		15,224,692
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share:		33,449,701		3,580,790		33,449,701		3,580,790		29,910,279

(j) Reclassification

Certain comparative amounts were reclassified to conform to the Company’s post-Merger presentation.

Intangible Assets

6 Months Ended

Jun. 30, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 3. Intangible Assets

	As of June 30, 2013		As of December 31, 2012		Weighted average amortization period (years)
Acquired technology (see Note 5)	$	10,133	$	10,133		6.0
Patents		26,794		26,694		8.5
Total		36,927		36,827

Less: accumulated amortization		(5,298)		(2,783)
	$	31,629	$	34,044

In June 2011, the Company’s subsidiary acquired patents from Lycos, Inc. The gross carrying amount of those patents is comprised of the original purchase price of $3,200 and $196 of associated patent acquisition costs.

In August 2012, the Company purchased from Nokia Corporation a portfolio consisting of various patents and patent applications. The portfolio encompasses a broad range of technologies relating to telecom infrastructure, including communication management, data and signal transmission, mobility management, radio resources management and services. The total consideration paid for the portfolio was $22,000. In addition, the Company capitalized certain costs related to the acquisition of patents in the total amount of $548. Under the terms of the purchase agreement, to the extent that the gross revenue generated by such portfolio exceeds $22,000, the Company is obligated to pay a royalty of 35% of such excess. The Company has not recorded any amounts in respect of this contingent consideration as both the amounts of future potential revenue, if any, and the timing of such revenue cannot be reliably established.

In October 2012, the Company’s subsidiary entered into an additional patent purchase agreement. As partial consideration, the Company issued 160,600 shares of common stock to the seller with the fair value of $750. In addition, under the terms of the purchase agreement, 20% of the gross revenue collected will be payable to the seller as a royalty. The Company has not recorded any amounts in respect of this contingent consideration as both the amounts of future potential revenue, if any, and the timing of such revenue cannot be reliably established.

During the three and six month periods ended June 30, 2013, the Company recorded amortization expense of $1,260 and $2,515, respectively. During the three and six month periods ended June 30, 2012, the Company recorded amortization expense of $156 and $311, respectively. During the period from June 8, 2011 (“Inception”) through June 30, 2013, total amortization expense of $5,298 was recorded. Estimated amortization expense for each of the five succeeding years, based upon intangible assets owned at June 30, 2013 is as follows:

Period ending December 31,	Amount
2013 (six months ending December 31, 2013)	$	2,489
2014		5,009
2015		5,009
2016		4,618
2017 and thereafter		14,504
	$	31,629

Fair Value Measurements

6 Months Ended

Jun. 30, 2013

Fair Value Measurements [Abstract]

Fair Value Measurements

Note 4 . Fair Value Measurements

The Company measures fair value in accordance with ASC 820-10, “Fair Value Measurements and Disclosures” (formerly SFAS 157, “Fair Value Measurements”). ASC 820-10 clarifies that fair value is an exit price, representing the amount that would be received by selling an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, ASC 820-10 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

Level 1 Inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date.

Level 2 Inputs: Inputs are based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The Company measures its derivative liabilities at fair value. The Special Bridge Warrants, Conversion Warrants, Preferential Reload Warrants and the majority of Series 1 Warrants (as they are defined in Note 6) are classified within Level 3 because they are valued using the Black-Scholes-Merton and the Monte-Carlo models (as all of these warrants include down-round protection clauses), which utilize significant inputs that are unobservable in the market.

The following table presents the Company’s assets and liabilities measured at fair value on a recurring basis as of June 30, 2013 and December 31, 2012, aggregated by the level in the fair-value hierarchy within which those measurements fall:

			Fair value measurement at reporting date using
			Quoted prices in
			active markets		Significant other		Significant
			for identical		observable		unobservable
Derivative liabilities on account of warrants	Balance		assets (Level 1)		inputs (Level 2)		inputs (Level 3)
Liabilities as of June 30, 2013	$	5,655		—		—	$	5,655

Liabilities as of December 31, 2012	$	7,612		—		—	$	7,612

In addition to the above, the Company’s financial instruments at June 30, 2013 and December 31, 2012 consisted of cash, cash equivalents, short-term investments, accounts receivable, accounts payable and long term deposits. The carrying amounts of all the aforementioned financial instruments approximate fair value. The following table summarizes the changes in the Company’s liabilities measured at fair value using significant unobservable inputs (Level 3) during the period from Inception through June 30, 2013 :

	Level 3
Balance at Inception	$	—
Balance at December 31, 2011		—
Derivative warrants issued to I/P’s shareholders in connection with the Merger, July 19, 2012		21,954
Fair value of derivative warrants issued by Legal Parent (see Note 5)		3,162
Fair value adjustment, prior to exercise of warrants, included in statement of operations		156
Exercise of derivative warrants		(10,657)
Fair value adjustment at end of period, included in statement of operations		(7,003)
Balance at December 31, 2012		7,612
Net impact of removal of down-round clause in Series 1 Warrant (see Note 6)		(2,174)
Fair value adjustment, prior to exercise of warrants, included in statement of operations		(25)
Exercise of derivative warrants		(76)
Fair value adjustment at end of period, included in statement of operations		318
Balance at June 30, 2013	$	5,655

Valuation processes for Level 3 Fair Value Measurements

Fair value measurement of the derivative liability on account of Special Bridge Warrants, Conversion Warrants, Preferential Reload Warrants and Series 1 Warrants (as defined in Note 6) fall within Level 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.

Description	Valuation technique	Unobservable inputs	Range
		Volatility		51.34% – 57.19%
		Risk free interest rate		0.3% – 1.08%
Special Bridge Warrants, Conversion	Black-Scholes-	Expected term, in years		1.50 – 4.05
Warrants, Preferential Reload	Merton and the	Dividend yield		0%
Warrants and the Series 1 Warrants	Monte-Carlo models	Probability and timing of down-round triggering event		15% occurrence in December 2013

Sensitivity of Level 3 measurements to changes in significant unobservable inputs

The inputs to estimate the fair value of the Company’s derivative warrant liability are the current market price of the Company’s shares of common stock, the exercise price of the warrant, its remaining expected term, the volatility of the Company’s common stock market price, the Company’s estimations regarding the probability and timing of a down-round protection triggering event and the risk-free interest rate. Significant changes in any of those inputs in isolation can result in a significant change in the fair value measurement. Generally, a positive change in the market price of the Company’s shares of common stock, and an increase in the volatility of the Company’s shares of common stock, or an increase in the remaining term of the warrant, or an increase of a probability of a down-round triggering event would each result in a directionally similar change in the estimated fair value of the Company’s warrants and thus an increase in the associated liability and vice-versa. An increase in the risk-free interest rate or a decrease in the positive differential between the warrant’s exercise price and the market price of the Company’s shares of common stock would result in a decrease in the estimated fair value measurement of the warrants and thus a decrease in the associated liability. The Company has not, nor plans to, declare dividends on its shares of common stock, and thus, there is no change in the estimated fair value of the warrants due to the dividend assumption.

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Business Combination

6 Months Ended

Jun. 30, 2013

Business Combinations [Abstract]

Business Combination

Note 5 . Business Combination

On July 19, 2012, I/P consummated the Merger with the Legal Parent, as also described in Note 1. The consideration consisted of various equity instruments, including: shares of common stock, preferred stock, options and warrants. The purpose of the Merger was to increase the combined company's intellectual property portfolio and array of products, to gain access to capital markets, and for other reasons. Upon completion of the Merger, (i) all then outstanding 6,169,661 common stock shares of I/P, par value $0.0001 per share, were exchanged for 18,617,569, shares of the Company’s common stock, par value $0.01 per share, and (ii) all then outstanding shares of Series A Convertible Preferred Stock of I/P, par value $0.0001 per share, were exchanged for 6,673 shares of the Legal Parent’s Series A Convertible Preferred Stock, par value $0.01 per share, which shares were convertible into 20,136,445 shares of common stock of the Legal Parent. In addition, the Legal Parent issued to the holders of I/P capital stock an aggregate of 15,959,838 warrants to purchase an aggregate of 15,959,838 shares of the Company’s common stock with an exercise price of $1.76 per share. The Company recorded such warrants as a derivative long-term liability in the total amount of $ 21,954. In addition, all outstanding and unexercised options to purchase I/P common stock, whether vested or unvested, were converted into 41,178 options to purchase the Company’s common stock. Immediately following the completion of the Merger, the former stockholders of I/P owned approximately 55.04% of the outstanding common stock of the combined company (or 67.61% of the outstanding shares of the Company’s common stock, calculated on a fully diluted basis), and the Legal Parent’s stockholders prior to the Merger owned approximately 44.96% of the outstanding common stock of the combined company (or 32.39% of the outstanding shares of its common stock calculated on a fully diluted basis). For accounting purposes, I/P was identified as the accounting “acquirer”, as it is defined in FASB Topic ASC 805. The total purchase price of $75,654 was allocated to the assets acquired and liabilities assumed of the Legal Parent. Registration and issuance cost, in the total amount of $463, was recorded against the additional paid-in capital.

	Allocation of purchase price
Current assets, net of current liabilities	$	2,586
Long-term deposit		8
Property and equipment		124
Technology		10,133
Goodwill		65,965
Total assets acquired, net		78,816

Fair value of outstanding warrants granted by Legal Parent prior to the Merger, classified as a long-term derivative liability		(3,162)
Total liabilities assumed, net		(3,162)

		75,654
Measurement of consideration:
Fair value of vested stock options granted to employees, management and consultants, classified as equity		7,364
Fair value of outstanding warrants granted by the Legal Parent prior to the Merger, classified as equity		10,079
Fair value of Vringo shares of common stock and vested $0.01 options granted to employees, management and consultants		58,211
Total estimated purchase price	$	75,654

The fair values of the identified intangible assets were estimated using an income approach. Under the income approach, an intangible asset’s fair value is equal to the present value of future economic benefits to be derived from ownership of the asset. Indications of value are developed by discounting future net cash flows to their present value at market-based rates of return. The goodwill recognized as a result of the acquisition is primarily attributable to the value of the workforce and other intangible asset arising as a result of operational synergies, products, and similar factors which could not be separately identified. The useful life of the intangible assets for amortization purposes was determined considering the period of expected cash flows used to measure the fair value of the intangible assets adjusted as appropriate for the entity-specific factors including legal, regulatory, contractual, competitive economic or other factors that may limit the useful life of intangible assets. Goodwill recognized is not deductible for income tax purposes. Had the acquisition taken place on Inception, the revenue in the consolidated statement of operations and the consolidated net loss would have been as follows:

	Cumulative from Inception to June 30, 2013				Six month period ended June 30, 2012				Three month period ended June 30, 2012
		Revenue	Net Loss		Revenue		Net Loss		Revenue		Net Loss
Total amount	$	2,235	$	(64,914)	$	206	$	(15,369)	$	100	$	(7,430)

The pro forma adjustment consists of amortization of acquired technology. The amortization, net, for the period from Inception through June 30, 2013 would have been $1,853. The amortization for the three and six month period ended June 30, 2012 would have been $422 and $844 , respectively. The above pro forma disclosure excludes the possible impact of valuation of equity and derivative instruments valued in connection with the Merger.

Stockholders' Equity Note [Abstract]

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

+ Details

Stockholders' Equity

6 Months Ended

Jun. 30, 2013

Stockholders' Equity

Note 6 . Stockholders’ Equity

Pre-Merger common stock share amounts and balance sheet disclosures were retrospectively restated to reflect Vringo’s equity instruments after the Merger.

(a) Common Stock

The following table summarizes information about the Company's issued and outstanding common stock from Inception through June 30, 2013:

	Shares of common stock
Balance as of June 8, 2011 (Inception)		—
Grant of shares at less than fair value to officers, directors and consultants		8,768,014
Issuance of shares of common stock		8,204,963
Balance as of December 31, 2011		16,972,977
Conversion of Series A Preferred Convertible Preferred stock, classified as mezzanine equity		890,192
Grant of shares to consultants		265,000
Legal Parent’s shares of common stock, recorded upon Merger		15,206,118
Exercise of 250,000 warrants, issued and exercised prior to the Merger		754,400
Post-Merger exercise of warrants		6,832,150
Exercise of stock options and RSUs		726,346
Conversion of Series A Preferred Convertible Preferred stock, classified as equity		20,136,445
Issuance of shares of common stock in connection with $31,148 received in a private financing round, net of issuance cost of $52		9,600,000
Issuance of shares of common stock in connection with $44,962 received in a private financing round, net of issuance cost of $39		10,344,998
Shares issued for acquisition of patents, see Note 3		160,600
Balance as of December 31, 2012		81,889,226
Exercise of warrants		99,147
Exercise of stock options and vesting of RSUs		969,297
Balance as of June 30, 2013		82,957,670

(b) Equity Incentive Plan

In August 2011, I/P adopted its 2011 Equity and Performance Incentive Plan (the “I/P 2011 Plan”). The I/P 2011 Plan provided for the issuance of stock options and restricted stock to the Company’s directors, employees and consultants. Terminated, expired or forfeited grants may be reissued under the I/P 2011 Plan. The number of shares available under I/P 2011 Plan was subject to adjustments for certain changes. Following the Merger with the Legal Parent, the I/P 2011 Plan was assumed by the Company.

On July 19, 2012, following the Merger with the Legal Parent, the Company’s stockholders approved the 2012 Employee, Director and Consultant Equity Incentive Plan (“2012 Plan”), replacing the existing 2006 Stock Option Plan of the Legal Parent, and the remaining 9,100,000 authorized shares thereunder were cancelled. The Company’s 2012 Plan was approved in order to ensure full compliance with legal and tax requirements under U.S. law. The number of shares subject to the 2012 Plan is the sum of: (i) 15,600,000 shares of common stock, which constitutes 6,500,000 new shares and 9,100,000 previously authorized but unissued shares under the 2006 Stock Option Plan and (ii) any shares of common stock that are represented by awards granted under the Legal Parent’s 2006 Stock Option Plan that are forfeited, expired or are cancelled without delivery of shares of common stock or which result in the forfeiture of shares of common stock back to the Company, or the equivalent of such number of shares after the administrator, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction in accordance with the 2012 Plan; provided, however, that no more than 3,200,000 shares shall be added to the 2012 Plan. As of June 30, 2013, 3,604,218 shares were available for future grants under the 2012 Plan.

(c) Stock options and RSUs

The following table illustrates the common stock options granted for the six month period ended June 30, 2013:

Title

Grant date

No. of
options

Exercise price

Share price at

grant date

Vesting terms

Assumptions used in Black-Scholes option
pricing model

Volatility

61.93%-70.51%

Management, Directors and

January-May 2013

3,065,833

$2.85-$3.2 4

Over 0.67-3 years

Risk free interest rate

0.85%- 2.06%

Employees *

Expected term, in years

5. 71-10.00

Dividend yield

0.00%

Volatility

63.87%-69.6%

Consultants *

January-June 2013

132,500

$2.9 0-$3.30

Over 0 -2.5 years

Risk free interest rate

1.86%-2.71%

Remaining expected term, in years

9.75-10

Dividend yield

0.00%

The following table illustrates the RSUs granted for the six month period ended June 30, 2013:

Title

Grant date

No. of RSUs

Exercise price

Share price at grant date

Vesting terms

Management, directors and employees *

F eb ruary-May 2013

656,250

—

$2.95-$3.18

Over 0.67 -3 years

Consultants *

January 2013

33,000

—

$3.26

Over 0.75 years

*	Certain options granted to officers, directors and certain key employees are subject to acceleration of vesting of 75% - 100% (according to the agreement signed with each optionee), upon a subsequent change of control.

The following table summarizes information about stock option and RSU activity for the six month period ended June 30, 2013:

	RSUs				Options
	No. of RSUs		Weighted average grant date fair value		No. of options		Weighted average exercise price		Exercise price range		Weighted average grant date fair value
Outstanding at January 1, 2013		3,125,000	$	3.72		9,149,105	$	3.33		$0.01 – $5.50	$	2.57
Granted		689,250	$	3.17		3,198,333	$	3.14		$2.85 – $3.30	$	2.23
Exercised		(790,330)	$	3.62		(178,967)	$	0.85		$0.01 – $3.00	$	3.23
Forfeited		(208,126)	$	3.72		(232,404)	$	3.54		$0.01 – $5.50	$	2.28
Expired		—		—		(19,375)	$	3.59		$3.33 – $5.50	$	2.40
Outstanding at June 30, 2013		2,815,794	$	3.61		11,916,692	$	3.31		$0.01 – $5.50	$	2.47
Exercisable at June 30, 2013		—		—		5,706,237	$	3.19		$0.01 – $5.50

For the three month periods ended June 30, 2013 and 2012, the Company recorded a stock -based compensation expense of $3,022 and $85, respectively. For the six month periods ended June 30, 2013 and 2012, the Company recorded stock -based compensation expense of $6,116 and $169, respectively. Cumulative from Inception through June 30, 2013, the Company has recorded stock -based compensation expense of $14,677.

The Company cumulatively did not create tax benefits related to its stock-based compensation due to a full valuation allowance.

(d) Warrants

The following table summarizes information about warrant activity for the six month period ended June 30, 2013:

	No. of warrants		Weighted average exercise price		Exercise price range
Outstanding at January 1, 2013		18,863,261	$	3.11		$0.94 – $5.06
Granted		—		—		—
Exercised		(99,147)	$	1.76		$1.76
Outstanding at June 30, 2013		18,764,114	$	3.12		$0.94 – $5.06

The Company’s outstanding warrants consisted of the following:

( 1) Series 1 and Series 2 Warrants

As part of the Merger, on July 19, 2012, the Legal Parent issued to I/P’s stockholders 8,299,116 warrants at an exercise price of $1.76 per share and contractual term of 5 years (“Series 1 Warrant”). These warrants bear down-round protection clauses and as a result, they were initially classified as a long-term derivative liability and recorded at fair value. In addition, I/P’s stockholders received another 7,660,722 warrants at an exercise price of $1.76 per share and contractual term of 5 years (“Series 2 Warrant”). As the Series 2 Warrants do not have down-round protection clauses, they were classified as equity.

As part of the issuance of October 2012 Warrants, the down-round protection clause in 2,173,852 then outstanding Series 1 Warrants was removed. The overall impact of the removal of the down-round warrant protection, which was not material, was recorded during the three month period ended June 30, 2013. As a result, the Company recorded an additional non-operating expense of $1,574 and re-classified $3,748 from derivative liabilities on account of warrants to stockholders’ equity.

During the six month period ended June 30, 2013, 53,957 Series 1 Warrants and 45,190 Series 2 Warrants were exercised. From Inception and through June 30, 2013, 4,709,056 Series 1 Warrants and 1,326,060 Series 2 Warrants were exercised.

( 2) Conversion Warrants, Special Bridge Warrants and Reload Warrants

On July 19, 2012, the date of the Merger, Legal Parent’s outstanding warrants included: (i) 148,390 derivative warrants, at an exercise price of $0.94 per share, with a remaining contractual term of 2.44 years (the “Special Bridge Warrants”); (ii) 101,445 derivative warrants, at an exercise price of $0.94 per share, with a remaining contractual term of 2.44 years (the “Conversion Warrants”); (iii) 887,330 derivative warrants, at an exercise price of $1.76 per share, with a remaining contractual term of 4.55 years (the “Preferential Reload Warrants”); and (iv) 814,408 warrants, classified as equity, at an exercise price of $1.76 per share, with a remaining contractual term of 4.55 years (the “non-Preferential Reload Warrants”). During the six month period ended June 30, 2013, none of these warrants were exercised. From Inception and through June 30, 2013, 169,520 non-Preferential Reload Warrants and 726,721 Preferential Reload Warrants were exercised.

( 3) Initial Public Offering Warrants

Upon completion of its initial public offering, the Legal Parent issued 4,784,000 warrants at an exercise price of $5.06 per share. These warrants are publicly traded and are exercisable until June 21, 2015, at an exercise price of $5.06 per share. As of June 30, 2013, all of these warrants were outstanding and classified as equity instruments.

( 4) October 2012 Warrants

On October 12, 2012, the Company entered into an agreement with certain of its warrant holders, pursuant to which, on October 23 and 24, 2012, the holders exercised in cash 3,721,062 of their outstanding warrants, with an exercise price of $1.76 per share. In exchange, the Company granted such warrant holders unregistered warrants of the Company to purchase an aggregate of 3,000,000 shares of the Company’s common stock, par value $0.01 per share, at an exercise price of $5.06 per share (the “October 2012 Warrants”). The contractual life of these warrants is 2.66 years and because such warrants do not bear any down-round protection clauses they were classified as equity instruments. October 2012 Warrants were valued using the following assumptions: volatility: 68.1%, share price: $3.50-$3.77, risk free interest rate: 0.724% and dividend yield: 0%. The fair value of warrants issued in exchange for the exercise of the Company’s derivative warrants was accounted for as an inducement, therefore an amount of $2,883, was recorded as a non-operating expense. As of June 30, 2013, all October 2012 Warrants were outstanding.

Commitments and Contingencies [Abstract]

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph d
-Article 4

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

+ Details

Revenue from Settlement and Licensing Agreement	6 Months Ended
Revenue from Settlement and Licensing Agreement	Jun. 30, 2013
Revenue from Settlement and Licensing Agreement [Abstract]
Revenue from Settlement and Licensing Agreement	Note 7. Revenue from Settlement and Licensing Agreement On May 30, 2013, Company’s subsidiary entered into a settlement and license agreement with Microsoft Corporation to resolve its patent litigation pending in the U.S. District Court for the Southern District of New York (I/P Engine, Inc. v. Microsoft Corporation, Case No. 1:13-cv-00688 (SDNY)). According to the agreement, Microsoft Corporation paid the Company $1,000 and agreed to pay 5% of any future amount Google pays for its use of the patents acquired from Lycos. The parties also agreed to a limitation on Microsoft Corporation's total liability, which would not impact the Company unless the amounts received from Google substantially exceed the judgment previously awarded. In addition, the parties also entered into a patent assignment agreement, pursuant to which Microsoft Corporation assigned six patents to I/P Engine. The assigned patents relate to telecommunications, data management, and other technology areas.

Commitments and Contingencies

6 Months Ended

Jun. 30, 2013

Commitments and Contingencies

Note 8. Commitments and Contingencies

(a)

Litigation and legal proceedings

The Company retains the services of professional service providers, including law firms that specialize in intellectual property licensing, enforcement and patent law. These service providers are often retained on an hourly, monthly, project, contingent or a blended fee basis. In contingency fee arrangements, a portion of the legal fee is based on predetermined milestones or the Company’s actual collection of funds. The Company accrues contingent fees when it is probable that the milestones will be achieved and the fees can be reasonably estimated.

From October 2012 through June 30, 2013, the Company’s subsidiaries filed patent infringement lawsuits against the subsidiaries of ZTE Corporation in the United Kingdom, France, Germany, and Australia. In most jurisdictions, an unsuccessful plaintiff may be required to pay a portion of the other party’s legal fees. Pursuant to negotiation with ZTE’s United Kingdom subsidiary, the Company placed two guarantees, in November 2012 and May 2013, to ensure payment should a liability by Vringo Infrastructure arise as a result of the two cases it filed. Defendants estimated the total possible liability to be no more than $2,900 for each case.

In addition, the Company may be required to grant additional guarantees, as necessary, in connection with its commenced proceedings against ZTE Corporation and its subsidiaries in Europe and Australia. It should be noted, however, that if the Company were successful on any court applications or the entirety of any litigation, ZTE Corporation would be responsible for a substantial portion of the Company’s legal fees.

(b)

Leases

The Company has entered into various operating lease agreements. Rent expense, which is primarily for our office spaces, for the six month periods ended June 30, 2013 and 2012, was $107 and $22, respectively. Rent expense for the three month periods ended June 30, 2013 and 2012 was $63 and $14, respectively. The cumulative expense for the period from Inception until June 30, 2013, was $238.

Future minimum lease payments under non-cancelable operating leases for office space, as of June 30, 2013, are as follows:

Period ending December 31,	Amount
2013 (six months ending December 31, 2013)	$	121
2014		199
2015		124
2016		5
	$	449

Risks and Uncertainties

6 Months Ended

Jun. 30, 2013

Risks and Uncertainties [Abstract]

Risks and Uncertainties

Note 9. Risks and Uncertainties

(a)

New legislation, regulations or rulings that impact the patent enforcement process or the rights of patent holders, could negatively affect the Company’s current business model. For example, limitations on the ability to bring patent enforcement claims, limitations on potential liability for patent infringement, lower evidentiary standards for invalidating patents, increases in the cost to resolve patent disputes and other similar developments could negatively affect the Company’s ability to assert its patent or other intellectual property rights.

(b)

As part of the Company’s ongoing legal proceedings, the validity and/or enforceability of its patents is often challenged in a court or an administrative proceeding, as it is almost universal practice for the defendant in a patent litigation to seek to challenge the validity of the patent asserted in the same or a parallel proceeding and/or in an administrative proceedings before the relevant jurisdiction’s patent office. Currently, several of the Company’s patents are being challenged in several jurisdictions.

(c)

Financial instruments which potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents, short-term investments and accounts receivable. The Company maintains its cash, cash equivalents and short-term investments with various major financial institutions. These major financial institutions are located in the United States, Germany and Israel, and the Company’s policy is designed to limit exposure to any one institution.

(d)

A portion of the Company’s expenses are denominated in NIS, British Pound and Euro. If the value of the U.S. dollar weakens against the value of these currencies, there will be a negative impact on the Company’s operating costs. In addition, the Company is subject to the risk of exchange rate fluctuations to the extent it holds monetary assets and liabilities in these currencies.

Significant Accounting and Reporting Policies (Policies)

6 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

Basis of presentation

(a) Basis of presentation

Development stage enterprise

(b) Development stage enterprise

Translation into U.S. dollars

(c) Translation into U.S. dollars

Use of estimates

(d) Use of estimates

Cash and cash equivalents

(e) Cash and cash equivalents

Short-term investments

(f) Short-term investments

Revenue recognition

(g) Revenue recognition

Cost of revenue

(h) Cost of revenue

Net loss per share data

( i) Net loss per share data

									Cumulative
									from Inception
	Three months ended June 30,				Six months ended June 30,				to June 30,
	2013		2012		2013		2012		2013
Basic Numerator:
Net loss attributable to shares of common stock	$	(10,940)	$	(1,841)	$	(22,904)	$	(3,712)	$	(46,499)
Basic Denominator:
Weighted average number of shares of common stock outstanding during the period		82,625,295		14,700,170		82,406,883		13,844,037		41,596,664
Weighted average number of penny stock options		114,152		—		145,827		—		113,299
Basic common stock shares outstanding		82,739,447		14,700,170		82,552,710		13,844,037		41,709,963
Basic net loss per common stock share	$	(0.13)	$	(0.13)	$	(0.28)	$	(0.27)	$	(1.11)

Diluted Numerator:
Net loss attributable to shares of common stock	$	(10,940)	$	(1,841)	$	(22,904)	$	(3,712)	$	(46,499)
Increase in net loss attributable to Series 1 warrants		—		—		—		—		(2,482)
Increase in net loss attributable to Preferential Reload warrants		—		—		—		—		(135)
Increase in net loss attributable to Conversion warrants		—		—		—		—		(68)
Increase in net loss attributable to Special Bridge warrants		—		—		—		—		(100)
Diluted net loss attributable to shares of common stock:	$	(10,940)	$	(1,841)	$	(22,904)	$	(3,712)	$	(49,284)

Diluted Denominator:
Weighted average number of shares of common stock outstanding during the period		82,739,447		14,700,170		82,552,710		13,844,037		41,709,963
Weighted average number of Series 1 warrants outstanding during the period		—		—		—		—		1,223,067
Weighted average number of Preferential Reload warrants outstanding during the period		—		—		—		—		75,197
Weighted average number of Conversion warrants outstanding during the period		—		—		—		—		47,497
Weighted average number of Special Bridge warrants outstanding during the period		—		—		—		—		69,477
Diluted common stock shares outstanding		82,739,447		14,700,170		82,552,710		13,844,037		43,125,201
Diluted net loss per common stock share	$	(0.13)	$	(0.13)	$	(0.28)	$	(0.27)	$	(1.14)
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as of June 30, as they had an anti-dilutive impact:
Both vested and unvested options at $0.96-$5.50 exercise price, to purchase an equal number of shares of common stock of the Company		11,805,940		—		11,805,940		—		11,805,940
Unvested $0.01 options to purchase an equal number of shares of common stock of the Company		2,375		—		2,375		—		2,375
Unvested Restricted Stock Units (“RSU”) to issue an equal number of shares of common stock of the Company		2,815,794		—		2,815,794		—		2,815,794
Common stock shares granted, but not yet vested		61,478		2,826,390		61,478		2,826,390		61,478
Warrants to purchase an equal number of shares of common stock of the Company		18,764,114		754,400		18,764,114		754,400		15,224,692
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share:		33,449,701		3,580,790		33,449,701		3,580,790		29,910,279

Reclassification

(j) Reclassification

Certain comparative amounts were reclassified to conform to the Company’s post-Merger presentation.

Significant Accounting and Reporting Policies (Tables)

6 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

Computation of Basic and Diluted Net Losses Per Common Share

The table below presents the computation of basic and diluted net losses per common share for the periods presented:

									Cumulative
									from Inception
	Three months ended June 30,				Six months ended June 30,				to June 30,
	2013		2012		2013		2012		2013
Basic Numerator:
Net loss attributable to shares of common stock	$	(10,940)	$	(1,841)	$	(22,904)	$	(3,712)	$	(46,499)
Basic Denominator:
Weighted average number of shares of common stock outstanding during the period		82,625,295		14,700,170		82,406,883		13,844,037		41,596,664
Weighted average number of penny stock options		114,152		—		145,827		—		113,299
Basic common stock shares outstanding		82,739,447		14,700,170		82,552,710		13,844,037		41,709,963
Basic net loss per common stock share	$	(0.13)	$	(0.13)	$	(0.28)	$	(0.27)	$	(1.11)

Diluted Numerator:
Net loss attributable to shares of common stock	$	(10,940)	$	(1,841)	$	(22,904)	$	(3,712)	$	(46,499)
Increase in net loss attributable to Series 1 warrants		—		—		—		—		(2,482)
Increase in net loss attributable to Preferential Reload warrants		—		—		—		—		(135)
Increase in net loss attributable to Conversion warrants		—		—		—		—		(68)
Increase in net loss attributable to Special Bridge warrants		—		—		—		—		(100)
Diluted net loss attributable to shares of common stock:	$	(10,940)	$	(1,841)	$	(22,904)	$	(3,712)	$	(49,284)

Diluted Denominator:
Weighted average number of shares of common stock outstanding during the period		82,739,447		14,700,170		82,552,710		13,844,037		41,709,963
Weighted average number of Series 1 warrants outstanding during the period		—		—		—		—		1,223,067
Weighted average number of Preferential Reload warrants outstanding during the period		—		—		—		—		75,197
Weighted average number of Conversion warrants outstanding during the period		—		—		—		—		47,497
Weighted average number of Special Bridge warrants outstanding during the period		—		—		—		—		69,477
Diluted common stock shares outstanding		82,739,447		14,700,170		82,552,710		13,844,037		43,125,201
Diluted net loss per common stock share	$	(0.13)	$	(0.13)	$	(0.28)	$	(0.27)	$	(1.14)
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as of June 30, as they had an anti-dilutive impact:
Both vested and unvested options at $0.96-$5.50 exercise price, to purchase an equal number of shares of common stock of the Company		11,805,940		—		11,805,940		—		11,805,940
Unvested $0.01 options to purchase an equal number of shares of common stock of the Company		2,375		—		2,375		—		2,375
Unvested Restricted Stock Units (“RSU”) to issue an equal number of shares of common stock of the Company		2,815,794		—		2,815,794		—		2,815,794
Common stock shares granted, but not yet vested		61,478		2,826,390		61,478		2,826,390		61,478
Warrants to purchase an equal number of shares of common stock of the Company		18,764,114		754,400		18,764,114		754,400		15,224,692
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share:		33,449,701		3,580,790		33,449,701		3,580,790		29,910,279

Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2013

Goodwill and Intangible Assets Disclosure [Abstract]

Components of Finite-Lived Intangible Assets

	As of June 30, 2013		As of December 31, 2012		Weighted average amortization period (years)
Acquired technology (see Note 5)	$	10,133	$	10,133		6.0
Patents		26,794		26,694		8.5
Total		36,927		36,827

Less: accumulated amortization		(5,298)		(2,783)
	$	31,629	$	34,044

Finite-Lived Intangible Assets, Future Amortization Expense

Estimated amortization expense for each of the five succeeding years, based upon intangible assets owned at June 30, 2013 is as follows:

Period ending December 31,	Amount
2013 (six months ending December 31, 2013)	$	2,489
2014		5,009
2015		5,009
2016		4,618
2017 and thereafter		14,504
	$	31,629

Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2013

Fair Value Measurements [Abstract]

Assets and Liabilities Measured at Fair Value on Recurring Basis

			Fair value measurement at reporting date using
			Quoted prices in
			active markets		Significant other		Significant
			for identical		observable		unobservable
Derivative liabilities on account of warrants	Balance		assets (Level 1)		inputs (Level 2)		inputs (Level 3)
Liabilities as of June 30, 2013	$	5,655		—		—	$	5,655

Liabilities as of December 31, 2012	$	7,612		—		—	$	7,612

Changes in Liabilities Measured at Fair Value Using Significant Unobservable Inputs

The following table summarizes the changes in the Company’s liabilities measured at fair value using significant unobservable inputs (Level 3) during the period from Inception through June 30, 2013 :

	Level 3
Balance at Inception	$	—
Balance at December 31, 2011		—
Derivative warrants issued to I/P’s shareholders in connection with the Merger, July 19, 2012		21,954
Fair value of derivative warrants issued by Legal Parent (see Note 5)		3,162
Fair value adjustment, prior to exercise of warrants, included in statement of operations		156
Exercise of derivative warrants		(10,657)
Fair value adjustment at end of period, included in statement of operations		(7,003)
Balance at December 31, 2012		7,612
Net impact of removal of down-round clause in Series 1 Warrant (see Note 6)		(2,174)
Fair value adjustment, prior to exercise of warrants, included in statement of operations		(25)
Exercise of derivative warrants		(76)
Fair value adjustment at end of period, included in statement of operations		318
Balance at June 30, 2013	$	5,655

Fair Value Measurements Based Upon Sensitivity and Nature of Inputs

The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.

Description	Valuation technique	Unobservable inputs	Range
		Volatility		51.34% – 57.19%
		Risk free interest rate		0.3% – 1.08%
Special Bridge Warrants, Conversion	Black-Scholes-	Expected term, in years		1.50 – 4.05
Warrants, Preferential Reload	Merton and the	Dividend yield		0%
Warrants and the Series 1 Warrants	Monte-Carlo models	Probability and timing of down-round triggering event		15% occurrence in December 2013

Business Combination (Tables)

6 Months Ended

Jun. 30, 2013

Business Combinations [Abstract]

Components of Recognized Identified Assets Acquired and Liabilities Assumed

	Allocation of purchase price
Current assets, net of current liabilities	$	2,586
Long-term deposit		8
Property and equipment		124
Technology		10,133
Goodwill		65,965
Total assets acquired, net		78,816

Fair value of outstanding warrants granted by Legal Parent prior to the Merger, classified as a long-term derivative liability		(3,162)
Total liabilities assumed, net		(3,162)

		75,654
Measurement of consideration:
Fair value of vested stock options granted to employees, management and consultants, classified as equity		7,364
Fair value of outstanding warrants granted by the Legal Parent prior to the Merger, classified as equity		10,079
Fair value of Vringo shares of common stock and vested $0.01 options granted to employees, management and consultants		58,211
Total estimated purchase price	$	75,654

Business Acquisition, Pro Forma Information

Had the acquisition taken place on Inception, the revenue in the consolidated statement of operations and the consolidated net loss would have been as follows:

	Cumulative from Inception to June 30, 2013				Six month period ended June 30, 2012				Three month period ended June 30, 2012
		Revenue	Net Loss		Revenue		Net Loss		Revenue		Net Loss
Total amount	$	2,235	$	(64,914)	$	206	$	(15,369)	$	100	$	(7,430)

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2013

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Components of Common Stock Outstanding

The following table summarizes information about the Company's issued and outstanding common stock from Inception through June 30, 2013:

	Shares of common stock
Balance as of June 8, 2011 (Inception)		—
Grant of shares at less than fair value to officers, directors and consultants		8,768,014
Issuance of shares of common stock		8,204,963
Balance as of December 31, 2011		16,972,977
Conversion of Series A Preferred Convertible Preferred stock, classified as mezzanine equity		890,192
Grant of shares to consultants		265,000
Legal Parent’s shares of common stock, recorded upon Merger		15,206,118
Exercise of 250,000 warrants, issued and exercised prior to the Merger		754,400
Post-Merger exercise of warrants		6,832,150
Exercise of stock options and RSUs		726,346
Conversion of Series A Preferred Convertible Preferred stock, classified as equity		20,136,445
Issuance of shares of common stock in connection with $31,148 received in a private financing round, net of issuance cost of $52		9,600,000
Issuance of shares of common stock in connection with $44,962 received in a private financing round, net of issuance cost of $39		10,344,998
Shares issued for acquisition of patents, see Note 3		160,600
Balance as of December 31, 2012		81,889,226
Exercise of warrants		99,147
Exercise of stock options and vesting of RSUs		969,297
Balance as of June 30, 2013		82,957,670

Stock Options and Restricted Stock Units Activity

The following table summarizes information about stock option and RSU activity for the six month period ended June 30, 2013:

	RSUs				Options
	No. of RSUs		Weighted average grant date fair value		No. of options		Weighted average exercise price		Exercise price range		Weighted average grant date fair value
Outstanding at January 1, 2013		3,125,000	$	3.72		9,149,105	$	3.33		$0.01 – $5.50	$	2.57
Granted		689,250	$	3.17		3,198,333	$	3.14		$2.85 – $3.30	$	2.23
Exercised		(790,330)	$	3.62		(178,967)	$	0.85		$0.01 – $3.00	$	3.23
Forfeited		(208,126)	$	3.72		(232,404)	$	3.54		$0.01 – $5.50	$	2.28
Expired		—		—		(19,375)	$	3.59		$3.33 – $5.50	$	2.40
Outstanding at June 30, 2013		2,815,794	$	3.61		11,916,692	$	3.31		$0.01 – $5.50	$	2.47
Exercisable at June 30, 2013		—		—		5,706,237	$	3.19		$0.01 – $5.50

Stockholders' Equity Note, Warrants or Rights

The following table summarizes information about warrant activity for the six month period ended June 30, 2013:

	No. of warrants		Weighted average exercise price		Exercise price range
Outstanding at January 1, 2013		18,863,261	$	3.11		$0.94 – $5.06
Granted		—		—		—
Exercised		(99,147)	$	1.76		$1.76
Outstanding at June 30, 2013		18,764,114	$	3.12		$0.94 – $5.06

Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule Of Common Stock Granted

The following table illustrates the common stock options granted for the six month period ended June 30, 2013:

Title

Grant date

No. of
options

Exercise price

Share price at

grant date

Vesting terms

Assumptions used in Black-Scholes option
pricing model

Volatility

61.93%-70.51%

Management, Directors and

January-May 2013

3,065,833

$2.85-$3.2 4

Over 0.67-3 years

Risk free interest rate

0.85%- 2.06%

Employees *

Expected term, in years

5. 71-10.00

Dividend yield

0.00%

Volatility

63.87%-69.6%

Consultants *

January-June 2013

132,500

$2.9 0-$3.30

Over 0 -2.5 years

Risk free interest rate

1.86%-2.71%

Remaining expected term, in years

9.75-10

Dividend yield

0.00%

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Components of Common Stock Outstanding

The following table illustrates the RSUs granted for the six month period ended June 30, 2013:

Title

Grant date

No. of RSUs

Exercise price

Share price at grant date

Vesting terms

Management, directors and employees *

F eb ruary-May 2013

656,250

—

$2.95-$3.18

Over 0.67 -3 years

Consultants *

January 2013

33,000

—

$3.26

Over 0.75 years

*	Certain options granted to officers, directors and certain key employees are subject to acceleration of vesting of 75% - 100% (according to the agreement signed with each optionee), upon a subsequent change of control.

Commitments and Contingencies [Abstract]

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

Commitments and Contingencies (Tables)

6 Months Ended

Jun. 30, 2013

Future Minimum Lease Payments Under Non Cancelable Operating Leases

Future minimum lease payments under non-cancelable operating leases for office space, as of June 30, 2013, are as follows:

Period ending December 31,	Amount
2013 (six months ending December 31, 2013)	$	121
2014		199
2015		124
2016		5
	$	449

General (Additional Information) (Details)	6 Months Ended
General (Additional Information) (Details)	Jun. 30, 2013
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Percentage Of Interest Owned Reverse Acquisition Transaction	67.61%

Significant Accounting and Reporting Policies (Computation of Basic and Diluted Net Losses Per Common Share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended		7 Months Ended	12 Months Ended	25 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2011	Dec. 31, 2012	Jun. 30, 2013
Basic Numerator:
Net loss attributable to shares of common stock	$ (10,940)	$ (1,841)	$ (22,904)	$ (3,712)	$ (2,754)	$ (20,841)	$ (46,499)
Basic Denominator:
Weighted average number of shares of common stock outstanding during the period	82,625,295	14,700,170	82,406,883	13,844,037			41,596,664
Weighted average number of penny stock options	114,152	0	145,827	0			113,299
Basic common stock shares outstanding	82,739,447	14,700,170	82,552,710	13,844,037			41,709,963
Basic net loss per common stock share	$ (0.13)	$ (0.13)	$ (0.28)	$ (0.27)			$ (1.11)
Diluted Numerator:
Net loss attributable to shares of common stock	$ (10,940)	$ (1,841)	$ (22,904)	$ (3,712)	$ (2,754)	$ (20,841)	$ (46,499)
Increase in net loss attributable to Series 1 warrants	0	0	0	0			(2,482)
Increase in net loss attributable to Preferential Reload warrants	0	0	0	0			(135)
Increase in net loss attributable to Conversion warrants	0	0	0	0			(68)
Increase in net loss attributable to Special Bridge warrants	0	0	0	0			(100)
Diluted net loss attributable to shares of common stock:	$ (10,940)	$ (1,841)	$ (22,904)	$ (3,712)			$ (49,284)
Diluted Denominator:
Weighted average number of shares of common stock outstanding during the period	82,739,447	14,700,170	82,552,710	13,844,037			41,709,963
Weighted average number of Series 1 warrants outstanding during the period	0	0	0	0			1,223,067
Weighted average number of Preferential Reload warrants outstanding during the period	0	0	0	0			75,197
Weighted average number of Conversion warrants outstanding during the period	0	0	0	0			47,497
Weighted average number of Special Bridge warrants outstanding during the period	0	0	0	0			69,477
Diluted common stock shares outstanding	82,739,447	14,700,170	82,552,710	13,844,037			43,125,201
Diluted net loss per common stock share	$ (0.13)	$ (0.13)	$ (0.28)	$ (0.27)			$ (1.14)
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as of June 30, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	33,449,701	3,580,790	33,449,701	3,580,790			29,910,279
Vested and unvested options at $0.96-$5.50 exercise price [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as of June 30, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	11,805,940	0	11,805,940	0			11,805,940
Unvested $0.01 options [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as of June 30, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	2,375	0	2,375	0			2,375
Unvested Restricted Stock Units (“RSU”) [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as of June 30, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	2,815,794	0	2,815,794	0			2,815,794
Common stock shares granted, but not yet vested [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as of June 30, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	61,478	2,826,390	61,478	2,826,390			61,478
Warrants to purchase an equal number of shares of common stock of the Company [Member]
Net loss per share data presented excludes from the calculation of diluted net loss the following potentially dilutive securities, as of June 30, as they had an anti-dilutive impact:
Total number of potentially dilutive instruments, excluded from the calculation of net loss per share	18,764,114	754,400	18,764,114	754,400			15,224,692

Significant Accounting and Reporting Policies (Additional Information) (Details) - Vested and Unvested Stock Option [Member]	6 Months Ended
	Jun. 30, 2013 $ / shares
Maximum [Member]
Significant Accounting Policies [Line Items]
Stock Option Exercise Price	$ 5.50
Minimum [Member]
Significant Accounting Policies [Line Items]
Stock Option Exercise Price	$ 0.96

Intangible Assets (Schedule of Finite-Lived Intangible Assets) (Details) - USD ($) $ in Thousands	1 Months Ended			6 Months Ended	12 Months Ended
	Oct. 31, 2012	Aug. 31, 2012	Jun. 30, 2011	Jun. 30, 2013	Dec. 31, 2012
Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired		$ 22,000
Total				$ 36,927	$ 36,827
Less: accumulated amortization				(5,298)	(2,783)
Finite-Lived Intangible Assets, Net				31,629	34,044
Acquired Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired				$ 10,133	$ 10,133
Weighted average amortization period (years)				6 years	6 years
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired	$ 750		$ 3,200	$ 26,794	$ 26,694
Weighted average amortization period (years)				8 years 6 months	8 years 6 months

Intangible Assets (Schedule of Finite-Lived Intangible Assets, Future Amortization Expense) (Details) - USD ($) $ in Thousands	Jun. 30, 2013	Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Line Items]
2013 (six months ending December 31, 2013)	$ 2,489
2014	5,009
2015	5,009
2016	4,618
2017 and thereafter	14,504
Finite-Lived Intangible Assets, Net	$ 31,629	$ 34,044

Intangible Assets (Additional Information) (Details) - USD ($) $ in Thousands	1 Months Ended			3 Months Ended		6 Months Ended		12 Months Ended	25 Months Ended
	Oct. 31, 2012	Aug. 31, 2012	Jun. 30, 2011	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012	Jun. 30, 2013
Finite-Lived Intangible Assets [Line Items]
Acquired Finite-lived Intangible Asset, Amount		$ 22,000
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization of Intangible Assets				$ 1,260	$ 156	$ 2,515	$ 311		$ 5,298
Acquired Finite-lived Intangible Asset, Amount	$ 750		$ 3,200			$ 26,794		$ 26,694
Royalty Payable On Excess Of Acquistion Cost	20.00%	35.00%
Capitalise Cost Related To Acquisition Of Patents		$ 548	$ 196
Stock Issued During Period, Shares, Acquisitions	160,600							160,600

Fair Value Measurements (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Details) - USD ($) $ in Thousands	Jun. 30, 2013	Dec. 31, 2012
Liabilities
Derivative liabilities on account of warrants	$ 5,655	$ 7,612
Fair Value, Inputs, Level 1
Liabilities
Derivative liabilities on account of warrants	0	0
Fair Value, Inputs, Level 2
Liabilities
Derivative liabilities on account of warrants	0	0
Fair Value, Inputs, Level 3
Liabilities
Derivative liabilities on account of warrants	$ 5,655	$ 7,612

Fair Value Measurements (Changes in Liabilities Measured at Fair Value Using Significant Unobservable Inputs) (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2013	Dec. 31, 2012
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Opening balance	$ 7,612	$ 0
Derivative warrants issued to I/P’s shareholders in connection with the Merger, July 19, 2012		21,954
Fair value of derivative warrants issued by Legal Parent (see Note 5)		3,162
Fair value adjustment, prior to exercise of warrants, included in statement of operations	(25)	156
Exercise of derivative warrants	(76)	(10,657)
Fair value adjustment at end of period, included in statement of operations	318	(7,003)
Closing balance	5,655	$ 7,612
Net impact of removal of down-round clause in Series 1 Warrant (see Note 6)	$ (2,174)

Fair Value Measurements (Based Upon Sensitivity and Nature of Inputs) (Details)	6 Months Ended
	Jun. 30, 2013
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Dividend yield	0.00%
Probability of down-round triggering event	15.00%
Timing of down-round triggering event	December 2013
Minimum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility	51.34%
Risk free interest rate	0.30%
Expected term, in years	1 year 6 months
Maximum [Member]
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]
Volatility	57.19%
Risk free interest rate	1.08%
Expected term, in years	4 years 18 days

Business Combination (Components of Recognized Identified Assets Acquired and Liabilities Assumed) (Details) $ in Thousands	Jun. 30, 2013 USD ($)
Business Combination [Line Items]
Current assets, net of current liabilities	$ 2,586
Long-term deposit	8
Property and equipment	124
Technology	10,133
Goodwill	65,965
Total assets acquired, net	78,816
Fair value of outstanding warrants granted by Legal Parent prior to the Merger, classified as a long-term derivative liability	(3,162)
Total liabilities assumed, net	(3,162)
Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net	75,654
Measurement of consideration:
Fair value of vested stock options granted to employees, management and consultants, classified as equity	7,364
Fair value of outstanding warrants granted by the Legal Parent prior to the Merger, classified as equity	10,079
Fair value of Vringo shares of common stock and vested $0.01 options granted to employees, management and consultants	58,211
Total estimated purchase price	$ 75,654

Business Combination (Business Acquisition, Pro Forma Information) (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended	25 Months Ended
	Jun. 30, 2012	Jun. 30, 2012	Jun. 30, 2013
Business Combination [Line Items]
Business Acquisition, Pro Forma Revenue	$ 100	$ 206	$ 2,235
Business Acquisition, Pro Forma Net Income (Loss)	$ (7,430)	$ (15,369)	$ (64,914)

Business Combination (Additional Information) (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended	12 Months Ended
	Jul. 31, 2012 $ / shares shares	Jul. 19, 2012 $ / Unit shares	Jun. 30, 2013 USD ($) $ / shares	Jun. 30, 2012 USD ($)	Jun. 30, 2012 USD ($)	Dec. 31, 2012 USD ($) $ / shares shares
Business Combination [Line Items]
Common stock converted upon completion of merger, shares	6,673
Common stock, par value \| $ / shares			$ 0.01			$ 0.01
Series A convertible preferred stock converted upon completion of merger, par value \| $ / shares	$ 0.01
Granted following the Merger						265,000
Payments of Stock Issuance Costs \| $						$ 463
Measurement of consideration \| $			$ 75,654
Common Stock [Member]
Business Combination [Line Items]
Conversion of Stock, Shares Issued						18,617,569
Merger Agreement [Member]
Business Combination [Line Items]
Conversion of Stock, Shares Issued		20,136,445
Granted following the Merger						41,178
Percentage of ownership of outstanding common stock						55.04%
Ownership Percentage Of Common Shares Outstanding Calculated On Fully Diluted Basis						67.61%
Merger Agreement [Member] \| Common Stock [Member]
Business Combination [Line Items]
Common stock converted upon completion of merger, shares						6,169,661
Common stock, par value \| $ / shares						$ 0.0001
Merger Agreement [Member] \| Series Preferred Stock [Member]
Business Combination [Line Items]
Warrants Issued		15,959,838
Aggregate of shares of common stock purchased by warrant		15,959,838
Exercise Price \| $ / Unit		1.76
Parent Company [Member]
Business Combination [Line Items]
Percentage of ownership of outstanding common stock						44.96%
Ownership Percentage Of Common Shares Outstanding Calculated On Fully Diluted Basis						32.39%
Patented Technology [Member]
Business Combination [Line Items]
Amortization of Intangible Assets \| $			$ 1,853	$ 422	$ 844

Stockholders' Equity (Issued And Outstanding Common Stock From Inception) (Details) - shares	1 Months Ended	6 Months Ended	7 Months Ended	12 Months Ended
	Oct. 31, 2012	Jun. 30, 2013	Dec. 31, 2011	Dec. 31, 2012
Balance		81,889,226	0	16,972,977
Conversion of Series A Preferred Convertible Preferred stock, classified as mezzanine equity				890,192
Grant of shares			8,768,014
Grant of shares to consultants				265,000
Legal Parent's shares of common stock, recorded upon Merger				15,206,118
Exercise of 250,000 warrants, issued and exercised prior to the Merger				754,400
Post-Merger exercise of warrants				6,832,150
Exercise of stock options and vesting of RSUs		969,297		726,346
Conversion of Series A Preferred Convertible Preferred stock, classified as equity				20,136,445
Issuance of shares of common stock		82,957,670		81,889,226
Exercise of warrants		99,147
Balance		82,957,670	16,972,977	81,889,226
Common Stock [Member]
Issuance of shares of common stock			8,204,963
Patents [Member]
Stock Issued During Period, Shares, Acquisitions	160,600			160,600
Private Financing [Member]
Issuance of shares of common stock				9,600,000
Private Financing One [Member]
Issuance of shares of common stock				10,344,998

Stockholders' Equity (Issued And Outstanding Common Stock From Inception) (Parenthetical) (Details) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2012 USD ($) shares
Class Of Warrant Or Right Exercise \| shares	250,000
Stock issuance cost	$ 463
Private Financing [Member]
Issuance of shares	31,148
Stock issuance cost	52
Private Financing One [Member]
Issuance of shares	44,962
Stock issuance cost	$ 39

Stockholders' Equity (Schedule Of Common Stock Option Granted) (Details)

6 Months Ended

Jun. 30, 2013

$ / shares

^[1]

Management Directors and Employees [Member]

January-May 2013

No. of Options | shares

3,065,833

Risk free interest rate, Minimum

Over 0.67-3 years

Volatility Rate, Minimum

61.93%

Volatility Rate, Maximum

70.51%

0.85%

Risk free interest rate, Maximum

2.06%

Dividend yield

0.00%

Management Directors and Employees [Member] | Maximum [Member]

$ 3.24

$ 3.24

Management Directors and Employees [Member] | Minimum [Member]

10 years

$ 2.85

$ 2.85

5 years 8 months 16 days

Consultant [Member]

January-June 2013

No. of Options | shares

132,500

Risk free interest rate, Minimum

Over 0-2.5 years

Volatility Rate, Minimum

63.87%

Volatility Rate, Maximum

69.60%

1.86%

Risk free interest rate, Maximum

2.71%

Dividend yield

0.00%

Consultant [Member] | Maximum [Member]

$ 3.30

$ 3.30

Consultant [Member] | Minimum [Member]

10 years

$ 2.90

$ 2.90

Management Directors and Employees [Member]

9 years 9 months

[1]	Certain options granted to officers, directors and certain key employees are subject to acceleration of vesting of 75% - 100% (according to theagreement signed with each optionee), upon a subsequent change of control.

Stockholders' Equity (RSUs granted) (Details)

6 Months Ended

Jun. 30, 2013

$ / shares

^[1]

January-May 2013

Management Directors and Employees [Member] | Maximum [Member]

Over 0.67-3 years

$ 3.24

Management Directors and Employees [Member] | Minimum [Member]

3.24

2.85

$ 2.85

Consultant [Member]

January-June 2013

Consultant [Member] | Maximum [Member]

Over 0-2.5 years

$ 3.30

Consultant [Member] | Minimum [Member]

3.30

2.90

Restricted Stock Units (RSUs) [Member] | Management Directors and Employees [Member]

$ 2.90

Restricted Stock Units (RSUs) [Member] | Management Directors and Employees [Member] | Maximum [Member]

February-May 2013

656,250

$ 0

Over 0.67-3 years

Restricted Stock Units (RSUs) [Member] | Management Directors and Employees [Member] | Minimum [Member]

$ 3.18

Restricted Stock Units (RSUs) [Member] | Consultant [Member]

$ 2.95

January 2013

No. of RSUs | shares

33,000

$ 0

$ 3.26